R E C O M B I N A N T E R Y T I I R O P O I E T I N (rhEPO) R E D U C E S T H E N E E D F O R
Rolf 635. The present study was undertaken to study the effect of oxygen exposure on lung hyaluronan concentration and lung water in rabbit pups born at tern). Some pups were kcpt in oxygen and some wcre kcpt in air. I'ups were sacrificed and lungs were taken nl an age of 4-6 days. Tl\e wakcr conteni was liiwhurcd as wcltdry wc~glil, and the l~ynluronan concentration will1 a r;ld~olilctric assny kit ( [ [ A 50, I'hnr~~incla, Ullpbnl;l).
Rcsulls: In tlic lu~igs from pups kept in oxygen significantly Iiigllcr hyaluronan concentrations were seen both at 4 (p<O.lXIl;n= 14) and 6 (p<O.OI;n= 17) d:lys o f age compared to the lungs from the pups kept in air (n=l5 and 29, rcspcctively). This was accompanied by a higher lung water conlcnt (p<0.001) than in pups kept in air al 4 dnys o f age. Conclusion: I n tcrlii rabbit pups lurig It);iluron;in conccritr;tllon ;~nd lulig \v.ltcr corllcnt 1ncrc.w during oxygcn expolure.
PCRSISTEIIT PULMOtiARY IIYPERTLIISION OF TllE NEWBORN (PPHN) I S SELECTIVELY LOWERED DY PROSTACYCLIN ( P C )
. , M a r l a n n e E r o n e n , M a l i a P o h i a v u o r l . E r k k l P e s o n e n . S t u r e A n d e r s s o n . K a r i 0 .
R a i v i p . C h i l d r e n ' s H o s p i t a l a n d D e p a r tm e n t o f Ob/Gyn, U n i v e r s i t y o f H e l s i n k i , F i n l a n d . PPHN i s a common i n d i c a t i o n f o r ECMO b e c a u s e o f s e v e r e h y p o x e m i a a n d m o r t a l i t y r i s k . We s t u d i e d t h e e f f e c t s o f PC
i n 0 i n f a n t s ( b . w t . 2 5 4 0 -4 1 3 0 g, g e s t . a g e 34-42 wk) w i t h r e s p i r a t o r y f a i l u r e a n d PPHN. A t mean a g e 19 ( r a n g e 3 -3 2 ) h , d e s p i t e m a x i m a l v e n t i l a t o r t h e r a p y a n d F i o 2 o f 1 . 0 , mcan pa02/PA02 was 0.07 ( r a n g e 0 . 0 4 -0 . 1 0 ) a n d AaDO2 614 ( 5 2 1 -6 4 0 ) mmHg. Mean p u l m o n a r y a r t e r y p r e s s u r e (PAP) b y e c h o c a r d i og r a p h y was 68 ( 6 4 -8 0 ) a n d s y s t e -m i c p r e s s u r e (DP) 59 ( 5 1 -6 4 ) mmHg. A f t e r v o l u m e c o r r e c t i o n a n d d u r i n g d o p a m i n e i n f u s i o n , PC was i n c r e a s e d s t e p w i s e f r o m a mean o f 1 0 t o 55 (max. 1 2 0 ) n g l k g l m i n i n 4 -1 2 h, a t w h i c h t i m e PAP h a d d e c r e a s e d t o 49 ( 4 5 -5 5 ) a n d DP t o 53 ( 4 2 -6 3 ) mmllg, PAP t h e r e a f t e r r e m a i n i n g b e l o w BP. A f t e r 7 2 h PAP Was 50 ( 2 5 -8 6 ) , BP 66 ( 5 5 -7 2 ) , paO2/PA02 0.14 (0.08-0.40), a n d AaDO2 429 ( 8 3 -6 0 5 ) a t F i 0 2 o f 0 . 5 9 . A l l p a t i e n t s s u r v i v e d w i t h o u t ECMO, PC was s t o p p e d a t 5.3 ( 3 -1 0 . 5 ) d a n d v e n t i l a t o r t h e r a p y a t 7 . The effect of surfactants In treatment of neonatal RDS IS well known However, the favourable results lncrease the demand for neonalal lnteslve care We collected retrospectively cllnlcal and follow-up dala of all 29 very low b~rlhwelght (VLBW) Infants who recelved surfactant In the OSlRlS study (from March 1991 to November 1991) and of 30 VLBW patlents born durtng the prevlous year who d~d not recelve surfactant treatment Patients were cl~g~bte lo the control group 11 they had at least once arler~at/alveolar oxygen ratlo <O 22
The gestational age, blrlhwe~ghl and blood pressure were s~m~lar In both groups Only 6 Infants In the control group survived and only 2 of them d~d not have any neurolog~cal sequelae In the OSlRlS group 20 s u~l v e d 9 w~thout neurological cornpllcallons The mean duratlon of neonatal lntens~ve care was 10 2 days In the controll group and 26 8 days In the OSlRlS group The mean durat~on of neonatal lntenslve care of the survivors was 32 days In both groups A slm~lar effect was observed on the tlme on resplrator, and on the durat~on of oxygen therapy and ol hosp~tal care
The costs of neonalal lntenslve care were In 1992 about 1500 US$ and the cost for care on a paed~atrlc ward were about 400 US$ per day Thus glvtng a VLBW Infant surfactant w~ll Increase the costs wllh al least 36 000 US$ The costs per survlvor were w~lhout surfactant about 3110 US$ and wlth surfactanl 2730 US$ The costs per healthy survlvor were 9330 US$ and 6670 US$, respectively This study illustrates the economical problems associated wtth lrnprovments of neonatal lntenslve care Although the prlce per survivor decreases the Increase of total costs IS very larqe The prlce of surfactant ltself IS almost neoltaible
